Serostim Market Report 2026

Serostim Market Overview

• The Serostim market growth in the historic period has been driven by availability of recombinant somatropin formulations, improved management of HIV-associated wasting • Market expansion is supported by increasing focus on quality-of-life improving therapies, rising adoption of adjunctive HIV treatments • Growth Driver: Impact Of Rising HIV/AIDS Incidence On The Growth Of The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Serostim Market?

Serostim refers to a recombinant human growth hormone (somatropin) specifically formulated to treat HIV-associated wasting or cachexia. It is used for improving body weight, lean body mass, and physical endurance in patients experiencing significant weight loss due to HIV. The main indication of chemicals in serostim is HIV-associated wasting syndrome and cachexia. HIV-associated wasting syndrome refers to a condition where individuals infected with HIV experience significant weight loss, muscle wasting, and a decrease in overall health due to the virus's impact on the body. Distribution channels include direct sales, pharmacies, and wholesalers. End-use settings comprise hospitals, clinics, ambulatory care, and home care.

What Is The Serostim Market Growth Forecast?

The growth in the forecast period can be attributed to increasing focus on quality-of-life improving therapies, rising adoption of adjunctive HIV treatments, expansion of home-based care models, growing demand for metabolic support therapies, advancements in long-acting hormone formulations. Major trends in the forecast period include increasing use of recombinant growth hormone therapies, rising focus on cachexia management, growing emphasis on body composition improvement treatments, expansion of long-term hormone therapy programs, enhanced monitoring of treatment outcomes.

Global Serostim Market Segmentation

1) By Indication: HIV-Associated Wasting Syndrome, Cachexia 2) By Distribution Channel: Direct Sales, Pharmacies, Wholesalers 3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

What Are The Drivers Of The Serostim Market?

The rising incidence of hiv/aids is expected to propel the growth of the serostim market going forward. Hiv/aids is a viral infection that weakens the immune system, potentially progressing to acquired immunodeficiency syndrome (AIDS) without treatment. The rising incidence of HIV/AIDS can be attributed to factors such as unprotected sex, limited access to healthcare, lack of awareness, and stigma and discrimination, all of which contribute to the spread of the virus. Serostim helps HIV/AIDS patients by promoting weight gain, increasing lean body mass, and improving physical strength, thereby combating the effects of HIV-associated wasting and enhancing overall quality of life. For instance, in October 2024, according to the UK Health Security Agency, a UK-based government agency, in 2023, England recorded 6,008 new HIV diagnoses, marking a 51% increase compared to the 3,975 diagnoses in 2022. Therefore, the rising incidence of hiv/aids is driving the growth of the serostim industry. The rising prevalence of target diseases is expected to propel the growth of the serostim market going forward. Target diseases are specific health conditions or illnesses that are the primary focus of treatment, intervention, or research due to their widespread occurrence or severity. The rising prevalence of target diseases is driven by factors such as aging populations, unhealthy lifestyle choices, environmental influences, and better detection methods. Serostim helps reverse or prevent muscle wasting and loss of lean body mass by stimulating growth hormone receptors to increase protein synthesis, thereby rebuilding muscle and tissue. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. Therefore, the rising prevalence of target diseases is driving the growth of the serostim industry. The growing incidence of chronic diseases is expected to propel the growth of the Serostim market going forward. Chronic diseases are long-lasting medical conditions that persist for a year or more, often requiring ongoing management and care, such as diabetes, heart disease, and asthma. Chronic diseases are increasing due to sedentary lifestyles, as reduced physical activity contributes to weight gain, metabolic imbalance, and weakened cardiovascular health. Serostim supports chronic diseases by improving muscle mass, energy levels, and metabolic stability in patients experiencing muscle wasting, and this enhancement strengthens physical functioning and helps individuals manage long-term health complications more effectively. For instance, in July 2024, according to the Australian Institute of Health and Welfare (AIHW), an Australia based government health statistics agency, chronic conditions made up 78% of the total fatal burden, marking an increase compared to earlier years. Therefore, the growing incidence of chronic diseases is driving the growth of the Serostim industry.

Key Players In The Global Serostim Market

Major companies operating in the serostim market are EMD Serono Inc.

Regional Insights

North America was the largest region in the serostim market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Serostim Market?

The serostim consists of sales of lyophilized powder for injection, pre-filled syringes, and cartridge formulations for injection pens. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Serostim Market Report 2026?

The serostim market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the serostim industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.